Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook

Revenue of $1.244 Billion Revenue Grew 9% as Reported and 6% on a Constant Currency1 Basis Compared to the First Quarter of 2025 GAAP Net Loss Attributable to Bausch + Lomb Corporation of $71 Million Adjusted EBITDA (non-GAAP)1 of $189 Million; Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)1 of $200 Million Raising Full-Year 2026 Revenue and … [Read more…]

PureTech Announces Annual Results for Year Ended December 31, 2025

Refined strategy and disciplined execution position Company to unlock value from its portfolio, which includes Celea Therapeutics’ Phase 3-ready deupirfenidone for idiopathic pulmonary fibrosis, Gallop Oncology’s clinically-validated LYT-200 for myeloid malignancies, and Seaport Therapeutics’ advancing clinical-stage pipeline for neuropsychiatric disorders PureTech level cash, cash equivalents and short-term investments of $277.1 million1 and Consolidated cash, cash … [Read more…]

TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access

HOUSTON–(BUSINESS WIRE)–TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its selection into the Caduceus LAUNCH digital health accelerator. The company has also opened a $1.5M round to accelerate growth. Founded by board-certified neurologist and clinical researcher Jontel Pierce, … [Read more…]

Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific

INCHEON, Korea & SHANGHAI–(BUSINESS WIRE)–#ATLATL–Samsung Bioepis Co., Ltd. and ATLATL Innovation Center (hereinafter referred to as “ATLATL”), global innovation platform for life science research and development, today announced that the companies have entered into a Memorandum of Understanding (MoU) on an open innovation program to accelerate early-stage biotech innovation in Asia-Pacific. Through this partnership, Samsung … [Read more…]

GenSight Biologics Announces Annual General Meeting to Take Place on May 19, 2026

Procedures for obtaining preparatory documents for the General Meeting are described below. PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that it will hold its Annual General Meeting on May 19, … [Read more…]

Preparing Tomorrow’s Doctors: Zucker School of Medicine Leaders Share Transformative Blueprint in “Revolutionizing Medical Education”

Book provides techniques for improving student outcomes and physician capability through innovative curriculum that replaces traditional teaching methods NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Roughly 20 years ago a new medical school turned medical education upside down by reimagining how future physicians are trained. Today, that school, the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, … [Read more…]

Dubai’s Medcare Hospital Becomes the World’s First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US

DUBAI, United Arab Emirates–(BUSINESS WIRE)–Medcare Royal Speciality Hospital (MRSH) in Dubai has become the world’s first hospital outside the USA, to offer a newly licensed intrathecal gene therapy – Itvisma, to adult patients with Spinal Muscular Atrophy (SMA). This one-time treatment was recently administered to a 22-year-old Egyptian patient, who was diagnosed at 18 months … [Read more…]

Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke

The Yankees, Red Sox, Phillies, Braves, Astros, Cardinals, Giants, Padres, and Angels are joining Merck to help educate fans about high bad cholesterol and how it may increase the risk of heart attack or stroke RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a collaboration with … [Read more…]

Roquette Showcases Its Expanded Consumer Healthcare Capabilities at Vitafoods Europe 2026

Experts will share insights on consumer ready innovations for everyday health at booth 3F112 LILLE, France–(BUSINESS WIRE)–Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will present its expanded portfolio at Vitafoods Europe 2026 which is taking place from May 5 to May 7 in Barcelona. Roquette’s offering is designed to help consumer … [Read more…]

MarinHealth Launches New Women’s Lifelong Health and Wellness Clinic to Support Women Through Midlife and Beyond

New program expands women’s health services with specialized care for menopause, hormonal health, and long-term wellness GREENBRAE, Calif.–(BUSINESS WIRE)–#Marin—MarinHealth today announced the launch of its Women’s Lifelong Health and Wellness Clinic, a new program designed to support women as they navigate the hormonal, cardiovascular, metabolic, mental and preventive health needs that often emerge in midlife … [Read more…]